Charles Schwab Investment Management Inc / BMY
Charles Schwab Investment Management Inc’s Bristol-Myers Squibb Co Position
Does Charles Schwab Investment Management Inc own Bristol-Myers Squibb Co (BMY)? Yes — 61.12M shares worth $3.7B (+0.57% of its 13F portfolio) as of Q1 2026, down from 71.32M shares the prior filed quarter.
Position Value
$3.7B
Q1 2026
Shares
61.12M
% of Portfolio
+0.57%
Quarters Held
30
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 61.12M | $3.7B | +0.57% |
| Q4 2025 | 71.32M | $3.8B | +0.60% |
| Q3 2025 | 73.04M | $3.3B | +0.53% |
| Q2 2025 | 70.80M | $3.3B | +0.57% |
| Q1 2025 | 60.61M | $3.7B | +0.69% |
| Q4 2024 | 60.30M | $3.4B | +0.63% |
| Q3 2024 | 61.03M | $3.2B | +0.60% |
| Q2 2024 | 59.06M | $2.5B | +0.47% |
| Q1 2024 | 53.72M | $2.9B | +0.67% |
| Q4 2023 | 11.36M | $583M | +0.15% |
| Q3 2023 | 11.23M | $652M | +0.19% |
| Q2 2023 | 11.23M | $718M | +0.20% |
| Q1 2023 | 11.35M | $787M | +0.24% |
| Q4 2022 | 11.21M | $806M | +0.26% |
| Q3 2022 | 11.14M | $792M | +0.28% |
| Q2 2022 | 10.82M | $834M | +0.29% |
| Q1 2022 | 11.01M | $804M | +0.24% |
| Q4 2021 | 10.81M | $674M | +0.20% |
| Q3 2021 | 10.68M | $632M | +0.21% |
| Q2 2021 | 10.35M | $692M | +0.23% |
| Q1 2021 | 10.15M | $641M | +0.23% |
| Q4 2020 | 10.52M | $653M | +0.26% |
| Q3 2020 | 10.50M | $633M | +0.29% |
| Q2 2020 | 11.16M | $656M | +0.32% |
| Q1 2020 | 19.62M | $1.1B | +0.64% |
| Q4 2019 | 19.66M | $1.3B | +0.68% |
| Q3 2019 | 13.80M | $700M | +0.41% |
| Q2 2019 | 13.43M | $609M | +0.37% |
| Q1 2019 | 12.84M | $612M | +0.39% |
| Q4 2018 | 6.81M | $354M | +0.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Charles Schwab Investment Management Inc’s full portfolio or all institutional holders of BMY.